KOELIS Regulatory Affairs Engineer Meylan, Isere 38240 Re: … · 2018. 8. 20. · U.S. Food & Drug...

8
U.S. Food & Drug Administration 10903 New Hampshire Avenue Doc ID# 04017.02.11 Silver Spring, MD 20993 www.fda.gov KOELIS ℅ Ms. Pauline Nicole Regulatory Affairs Engineer 16, chemin du vieux chêne Meylan, Isere 38240 FRANCE Re: K180970 Trade/Device Name: Disposable Guide KDNG00 Regulation Number: 21 CFR 892.1570 Regulation Name: Diagnostic ultrasonic transducer Regulatory Class: II Product Code: ITX Dated: June 13, 2018 Received: June 18, 2018 Dear Ms. Nicole: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Transcript of KOELIS Regulatory Affairs Engineer Meylan, Isere 38240 Re: … · 2018. 8. 20. · U.S. Food & Drug...

Page 1: KOELIS Regulatory Affairs Engineer Meylan, Isere 38240 Re: … · 2018. 8. 20. · U.S. Food & Drug Administration 10903 New Hampshire Avenue Doc ID# 04017.02.11 Silver Spring, MD

U.S. Food & Drug Administration 10903 New Hampshire Avenue D o c I D # 0 4 0 1 7 . 0 2 . 1 1 Silver Spring, MD 20993 www.fda.gov

KOELIS℅ Ms. Pauline NicoleRegulatory Affairs Engineer16, chemin du vieux chêneMeylan, Isere 38240FRANCE

Re: K180970Trade/Device Name: Disposable Guide KDNG00Regulation Number: 21 CFR 892.1570Regulation Name: Diagnostic ultrasonic transducerRegulatory Class: IIProduct Code: ITXDated: June 13, 2018Received: June 18, 2018

Dear Ms. Nicole:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2: KOELIS Regulatory Affairs Engineer Meylan, Isere 38240 Re: … · 2018. 8. 20. · U.S. Food & Drug Administration 10903 New Hampshire Avenue Doc ID# 04017.02.11 Silver Spring, MD

Page 2 – Ms. Pauline Nicole K180970

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email ([email protected]) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

Robert Ochs, Ph.D.DirectorDivision of Radiological HealthOffice of In Vitro Diagnostics

and Radiological HealthCenter for Devices and Radiological Health

Enclosure

Page 3: KOELIS Regulatory Affairs Engineer Meylan, Isere 38240 Re: … · 2018. 8. 20. · U.S. Food & Drug Administration 10903 New Hampshire Avenue Doc ID# 04017.02.11 Silver Spring, MD

������������ �� � Page 1 of 1 ���������� �������������������������������

����������� ���� �� ������������������������������������

�������������������

��������� !�"��#�$%&'%(%')%�*�����������!"%+,-%,)%)%������������������ ���

.'%/01��2!������������������

�! �3!��! !"#���� �$��� %&��

����3������4����!����������'���$!"#���� �$��� %&����$�$�#(�$�)"����$"�#�(*�$# �"���(�#"��$����$��� �$�$�!�"��$���+�,(���(��$�$�)"������#��#�$�#(#�(�����#�-��������#�$��"!(#�-�("� �$�����#���(��.��(�/(��#�(�#����(#��#!!�"#��+

�5�!�4��!��� ��������������������� ��� ��

��!�3���������!/����)'���6%'��2�����1 � !�(�7!(�����!���!/)'���6%'��2�����1

������� ������! "���� �"�# ����� � �$�

�7���!3�������8�!���85���!9���!�!����4�7!���!�:��0�!��3�����3��4'&&.$%�������! ���&�������"' � �����������( �"���!����� ���'����� !!�) '�*$%

�7!2���!����!4���7��3�88!3�����4��4����������!������!���� !���!;&7�����!��!�����!<��38������7!���!���! �!:������3�����<�!��37!*��������������3!�<���7!�������������7!�����!!�!����3���8!�!����! �!:�7!3�88!3�����4��4��������$�!��3���!����!��������7��2���!�!������!����5��7!����!3��4�7����4��������3�88!3����<��38���������!������4���!��3����7��2���!�<��"

�!�����!���4 !�8�7��� �����!� �3!���������������������������44�3!�4�7�!4��4���������44�3!����!�:��0�!��3�����3�/���1���44�����������������

!�������"�"���������#�����������������������������������$#����������������������� ��������������������#� ����������� "����#����� "� ���%&'��#����(

Page 4: KOELIS Regulatory Affairs Engineer Meylan, Isere 38240 Re: … · 2018. 8. 20. · U.S. Food & Drug Administration 10903 New Hampshire Avenue Doc ID# 04017.02.11 Silver Spring, MD
Page 5: KOELIS Regulatory Affairs Engineer Meylan, Isere 38240 Re: … · 2018. 8. 20. · U.S. Food & Drug Administration 10903 New Hampshire Avenue Doc ID# 04017.02.11 Silver Spring, MD
Page 6: KOELIS Regulatory Affairs Engineer Meylan, Isere 38240 Re: … · 2018. 8. 20. · U.S. Food & Drug Administration 10903 New Hampshire Avenue Doc ID# 04017.02.11 Silver Spring, MD
Page 7: KOELIS Regulatory Affairs Engineer Meylan, Isere 38240 Re: … · 2018. 8. 20. · U.S. Food & Drug Administration 10903 New Hampshire Avenue Doc ID# 04017.02.11 Silver Spring, MD
Page 8: KOELIS Regulatory Affairs Engineer Meylan, Isere 38240 Re: … · 2018. 8. 20. · U.S. Food & Drug Administration 10903 New Hampshire Avenue Doc ID# 04017.02.11 Silver Spring, MD